Seraticin is a novel antibiotic developed by scientists at Swansea University able to inhibit 12 different strains of MRSA, as well as E. coli and C. difficile. The research was funded by leading charity Action Medical Research, with support from the Rosetrees Trust. Seraticin was isolated as a compound of less than 500Da molecular weight from the maggot secretions of the common green bottle fly (Lucilia sericata). It was patented in 2008 and has the empirical formula C
10H
16N
6O
9.
References
Seraticin Wikipedia(Text) CC BY-SA